The American Medical Association (AMA) on Monday said it opposes the Senate Republicans’ bill for repealing and replacing ObamaCare.
“Medicine has long operated under the precept of Primum non nocere, or ‘first, do no harm,’” AMA Executive Vice President and CEO James Madara wrote in a letter to Senate leadership.
“The draft legislation violates that standard on many levels,” he continued in the letter to Senate Majority Leader Mitch McConnell (R-KY) and Senate Minority Leader Chuck Schumer (D-NY).
“Though we await additional analysis of the proposal, it seems highly likely that a combination of smaller subsidies resulting from lower benchmarks and the increased likelihood of waivers of important protections such as required benefits, actuarial value standards, and out of pocket spending limits will expose low and middle income patients to higher costs and greater difficulty in affording care.”
Sen. Jeanne Shaheen (D-NH) on Monday tweeted that GOP senators should heed the advice from the AMA, which ranks among America’s biggest healthcare lobbying groups.
Bradd Jaffy, a senior editor and news writer at “NBC Nightly News,” on Monday noted that the AMA supported ObamaCare’s creation.
Some Twitter uses on Monday cited the AMA’s concerns as evidence against implementing the plan to repeal and replace ObamaCare.
Senate Republicans on Monday also reportedly released an updated version of their healthcare reform bill.
The bill’s new provision purportedly adds a provision requiring consumers with a lapse in coverage of 63 days or more to wait six months before buying insurance.
The measure tackles the concern that people would only sign up for health coverage when they are sick if health insurers cannot deny coverage for preexisting conditions.
Senate Republicans can only afford two defections assuming all Democrats oppose the bill and Vice President Mike Pence then breaks a tie.
Five Republican senators oppose the controversial draft legislation, according to The Hill’s whip list, while 22 more are undecided or have unclear positions on the issue.